References
- HaiounCBessonCLepageEIncidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin’s lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d’Etudes des Lymphomes de l’AdulteAnn Oncol200011668569010942056
- JahnkeKThielEMartusPSchwartzSKorfelARetrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous systemAnn Hematol2006851455016132909
- BernsteinSHUngerJMLeblancMFriedbergJMillerTPFisherRINatural history of CNS relapse in patients with aggressive non-Hodgkin’s lymphoma: a 20-year follow-up analysis of SWOG 8516 – the Southwest Oncology GroupJ Clin Oncol200927111411919047289
- VillaDConnorsJMShenkierTNGascoyneRDSehnLHSavageKJIncidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapyAnn Oncol20102151046105219861575
- BiermanPGiglioPDiagnosis and treatment of central nervous system involvement in non-Hodgkin’s lymphomaHematol Oncol Clin North Am200519459760916083825
- GrimmSChamberlainMHodgkin’s lymphoma: a review of neurologic complicationsAdv Hematol2011201162457820975772
- HaldorsenISEspelandALarssonE-MCentral nervous system lymphoma: characteristic findings on traditional and advanced imagingAm J Neuroradiol201132698499220616176
- HillQAOwenRGCNS prophylaxis in lymphoma: who to target and what therapy to useBlood Rev200620631933216884838
- KeldsenNMichalskiWBentzenSMHansenKBThorlingKRisk factor for central nervous system involvement in non-Hodgkins-lymphoma – a multivariable analysisActa Oncol19963567037088938217
- van BesienKHaCSMurphySRisk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphomaBlood1998914117811849454747
- ZinzaniPLMagagnoliMFerezzaGIsolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experienceLeuk Lymphoma1999325–657157610048430
- HollenderAKvaloySNomeOSkovlundELoteKHolteHCentral nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk modelAnn Oncol20021371099110712176790
- PittmanMTreeseSChenLUtility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphomaArch Pathol Lab Med2013137111610161824168498
- BhagavathiSWilsonJDPrimary central nervous system lymphomaArch Pathol Lab Med2008132111830183418976024
- KoubskaEWeichetJMalikovaHCentral nervous system lymphoma: a morphological MRI studyNeuro Endocrinol Lett201637431832427857050
- Hernández RubioLGiner BernabeuJCPerez SempereAToroPPrimary cerebral lymphoma with spontaneous remissionNeurologia201328212312622037213
- MalikovaHKoubskaEWeichetJCan morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?Cancer Imaging20161614027894359
- HaldorsenISKråkenesJKrossnessBKMellaOEspelandACT and MR imaging features of primary central nervous system lymphoma in Norway, 1989–2003Am J Neuroradiol200930474475119164442
- SenocakEOguzKKOzgenBParenchymal lymphoma of the brain on initial MR imaging: a comparative study between primary and secondary brain lymphomaEur J Radiol201179228829420202775
- MalikovaHLiscakRLatnerovaIComplications of MRI-guided stereotactic biopsy of brain lymphomaNeuro Endocrinol Lett201435761361825617885